Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

655
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
655
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

811
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
811
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

12.4K
Vital-dye enhanced fluorescence imaging (VFI) is a novel in vivo technique that combines high-resolution epithelial imaging with exogenous topical fluorescent contrast to highlight glandular morphology and delineate neoplasia (high grade dysplasia and cancer) in the distal...
12.4K
Esophagus01:24

Esophagus

3.7K
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
3.7K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

14.4K
There is a discernible need for improved information on molecular drivers of Barrett’s Esophagus. Immunofluorescent staining is a useful technique for understanding the effects of cell signaling on cell morphology. We present a simple, effective protocol for the use of immunofluorescent staining to assess therapeutic treatment in Barrett’s Esophagus...
14.4K
Using the Endoscope for Endobronchial Ultrasound in the Esophagus04:35

Using the Endoscope for Endobronchial Ultrasound in the Esophagus

1.0K
Transesophageal ultrasound (EUS-B) is a safe and feasible procedure using the echoendobronchoscope (EBUS) in esophagus and stomach. After identifying six anatomical landmarks, additional structures can be identified and biopsied, sparing subsequent diagnostic sessions. Thus, EUS-B is an ideal continuation of bronchoscopy and EBUS in diagnosing lung cancer and other...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Nonendoscopic Tests for the Early Detection of Esophageal Squamous Carcinoma and High-Grade Dysplasia: Promising Progress.

The American journal of gastroenterology·2026
Same author

International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal Bleeding.

Journal of clinical gastroenterology·2026
Same author

If it breaks us, we must fix it! An ergonomic summit as a path to better ergonomics in endoscopy.

The American journal of gastroenterology·2026
Same author

Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1b Esophageal Adenocarcinoma: A Patient-Level Pooled Analysis of International Studies.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same author

The Epidemiology of Young-Onset Barrett's Esophagus in the United States: A National Population-Based Study Using the TriNetX Database.

Journal of clinical gastroenterology·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
Same journal

In Reply: Long-Term Cardiovascular Burden After Carotid Endarterectomy: Moving Beyond Conventional Risk Profiling.

Mayo Clinic proceedings·2026
Same journal

Long-Term Cardiovascular Burden After Carotid Endarterectomy: Moving Beyond Conventional Risk Profiling.

Mayo Clinic proceedings·2026
Same journal

Real-World Comparative Effectiveness of Tirzepatide and Semaglutide for Obesity: A Multicentered Study.

Mayo Clinic proceedings·2026
See all related articles

Related Experiment Video

Updated: Jan 20, 2026

Barrett Esophagus-I: Introduction
01:21

Barrett Esophagus-I: Introduction

655

Barrett Esophagus.

Prasad G Iyer1, Vivek Kaul2

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Mayo Clinic Proceedings
|September 6, 2019
PubMed
Summary
This summary is machine-generated.

Barrett esophagus, a precancerous condition, involves intestinal metaplasia in the esophagus. Early detection and endoscopic therapy improve outcomes for esophageal adenocarcinoma, but risk stratification remains challenging.

More Related Videos

Barrett Esophagus-II: Clinical Manifestations and Management
01:21

Barrett Esophagus-II: Clinical Manifestations and Management

811
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.4K

Related Experiment Videos

Last Updated: Jan 20, 2026

Barrett Esophagus-I: Introduction
01:21

Barrett Esophagus-I: Introduction

655
Barrett Esophagus-II: Clinical Manifestations and Management
01:21

Barrett Esophagus-II: Clinical Manifestations and Management

811
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.4K

Area of Science:

  • Gastroenterology and Oncology
  • Esophageal Diseases

Background:

  • Barrett esophagus is a precancerous condition involving intestinal metaplasia of the distal esophagus.
  • It significantly increases the risk of developing esophageal adenocarcinoma, a malignancy with poor prognosis.
  • Risk factors include GERD, obesity, and family history.

Purpose of the Study:

  • To review challenges and recent advancements in Barrett esophagus detection, treatment, and risk stratification.
  • To highlight the importance of early diagnosis and endoscopic surveillance.
  • To discuss the potential of new diagnostic tools and therapeutic strategies.

Main Methods:

  • This narrative review synthesizes current literature on Barrett esophagus.
  • It examines diagnostic criteria, risk factors, and surveillance guidelines.
  • It discusses endoscopic and non-endoscopic detection methods, and multimodality endoscopic therapy.

Main Results:

  • Barrett esophagus significantly elevates esophageal adenocarcinoma risk.
  • Endoscopic surveillance is recommended for high-risk individuals.
  • Multimodality endoscopic therapy shows promise for treating dysplasia and early adenocarcinoma.
  • Risk stratification remains a key challenge, with ongoing research into biomarkers.

Conclusions:

  • Early detection and endoscopic surveillance are crucial for managing Barrett esophagus and preventing esophageal adenocarcinoma progression.
  • Multimodality endoscopic therapy offers effective treatment options for early-stage disease.
  • Further research is needed to improve risk stratification and identify individuals at highest risk for progression.